Satellos Bioscience Inc
(MSCLF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2 | -704 | -490 | -1,461 | -954 |
| Depreciation Amortization | 47 | 1 | 1 | 2 | 0 |
| Other Working Capital | 222 | 222 | 80 | -228 | -329 |
| Other Operating Activity | -1,543 | 37 | 22 | 0 | 0 |
| Operating Cash Flow | $-1,271 | $-444 | $-387 | $-1,686 | $-1,283 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2 | -2 | -5 | N/A |
| Investing Cash Flow | $N/A | $-2 | $-2 | $-5 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 2,425 | 2,454 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $2,425 | $2,454 |
| Exchange Rate Effect | -9 | -4 | 9 | 5 | 4 |
| Beginning Cash Position | 743 | 714 | 738 | 8 | 8 |
| End Cash Position | 127 | 264 | 357 | 746 | 1,183 |
| Net Cash Flow | $-616 | $-450 | $-381 | $738 | $1,175 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,271 | -444 | -387 | -1,686 | -1,283 |
| Capital Expenditure | N/A | -2 | -2 | -5 | N/A |
| Free Cash Flow | -1,271 | -446 | -390 | -1,691 | -1,283 |